CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

Buckley, 2000, Imunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor., Eur J Pharmacol, 396, 141, 10.1016/S0014-2999(00)00211-9 Calignano, 1998, Control of pain initiation by endogenous cannabinoids., Nature, 394, 277, 10.1038/28393 Compton, 1992, Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents., J Pharmacol Exp Ther, 260, 201 Croci, 1998, In vitro functional evidence of neuronal cannabioid CB1 receptors in human ileum., Br J Pharmacol, 25, 1393, 10.1038/sj.bjp.0702190 Fan, 1994, Development of cross-tolerance between THC, CP55940 and WIN55212., J Pharmacol Exp Ther, 271, 1383 Galiegue, 1995, Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations., Eur J Biochem, 232, 54, 10.1111/j.1432-1033.1995.tb20780.x Gallant, 1996, New class of potent ligands for the human peripheral cannabinoid receptor., Bioorg Med Chem Lett, 6, 2263, 10.1016/0960-894X(96)00426-X Gatley, 1998, Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo., J Neurochem, 70, 417, 10.1046/j.1471-4159.1998.70010417.x Gifford, 1997, Effect of the cannabinoid receptor SPECT agent, AM281, on hippocampal acetylcholine release from rat brain slices., Neurosci Lett, 238, 84, 10.1016/S0304-3940(97)00851-3 Green, 1999, Reporter assays for human cannabinoid CB1 and CB2 receptors for the identification of novel agonists., Br J Pharmacol, 126, 112 Griffin, 1997, Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals., Eur J Pharmacol, 339, 53, 10.1016/S0014-2999(97)01336-8 Hanus, 1996, HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor., Proc Nat Acad Sci, 96, 14228, 10.1073/pnas.96.25.14228 Hohmann, 1999, Cannabionoid receptors undergo axonal flow in sensory nerves., Neuroscience, 92, 1171, 10.1016/S0306-4522(99)00220-1 Jagger, 1998, The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain., Pain, 76, 189, 10.1016/S0304-3959(98)00041-4 Lichtman, 1996, Tetrahydrocannabinol impairs spatial memory through a cannabioid receptor mechanism., Psychopharmacology, 126, 125, 10.1007/BF02246347 Lichtman, 1997, The selective cannabinoid antagonist SR141716A blocks cannabinoid-induced antinociception in rats., Pharm Biochem Behav, 57, 7, 10.1016/S0091-3057(96)00121-9 Lynn, 1994, Localisation of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids., J Pharmacol Exp Ther, 268, 1612 Pertwee, 1999, Evidence for the presence of CB1 canabinoid receptors on peripheral neurones and for the existence of neuronal non-cannabinoid receptors., Life Sci, 65, 597, 10.1016/S0024-3205(99)00282-9 Pertwee, 1999, Pharmacology of cannabinoid receptor ligands., Curr Med Chem, 6, 635, 10.2174/0929867306666220401124036 Randall, 1957, A method for measurement of analgesic activity on inflamed tissue., Arch Int Pharmacodyn, 61, 409 Richardson, 1998, Antihyperalgesic effects of spinal cannabinoids., Eur J Pharmacol, 345, 144, 10.1016/S0014-2999(97)01621-X Rinaldi-Carmona, 1994, SR141716A, a potent and selective antagonist of the brain cannabinoid receptor., FEBS Lett, 350, 240, 10.1016/0014-5793(94)00773-X Rinaldi-Carmona, 1996, Characterisation of two cloned human CB1 cannabinoid receptor isoforms., J Pharm Exp Ther, 278, 871 Rinaldi-Carmona, 1998, SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor., J Pharm Exp Ther, 284, 644 Sacerdote, 2000, In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors., J Neuroimmunol, 109, 155, 10.1016/S0165-5728(00)00307-6 Sanudo-Pena, 1999, CB1 receptor localisation in rat spinal cord and roots, dorsal root ganglion and peripheral nerve., Acta Pharmacologica Sinica, 20, 1115 Varga, 1995, Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide., Eur J Pharmacol, 78, 279, 10.1016/0014-2999(95)00181-J Zimmer, 1999, Increased mortality, hypoactivity and hypoalgesia in cannabinoid CB1 receptor knockout mice., Proc Natl Acad Sci USA, 96, 5780, 10.1073/pnas.96.10.5780